Clinical Trial Update: A Randomized Trial Comparing EC-wPversus EP-wP as Adjuvant Therapy for Operable Breast Cancer Patients Less Than 40 Years Old [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial comparing EC-wP versus EP-wP as adjuvant therapy for operable breast cancer in patients under 40 has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Neoplasms

Drugs mentioned

• EC-wP
• EP-wP

Snippet

Sponsor: Fudan University | Conditions: Breast Neoplasms | Phase 3 | Status: COMPLETED